Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer

World Journal of Gastroenterology

Volumn 15, Issue 19, 2009, Pages 2345-2350

  Salcido Neyoy, Martha Estela ^a   Sierra Santoyo, Adolfo ^a   Beltrán Ramírez, Olga ^a   Macías Pérez, José Roberto ^a   Villa Treviño, Saúl ^a  

^a Centre for Research and Advanced Studies (Cinvestav)   (Mexico)

Author keywords

Celecoxib; Chemoprevention; Cytochromes P450; Denitrosation; Diethylnitrosamine; Hepatocarcinogenesis

Indexed keywords

ACETALDEHYDE; CELECOXIB; CYTOCHROME P450 1A1; CYTOCHROME P450 2A; CYTOCHROME P450 2B1; CYTOCHROME P450 2B2; CYTOCHROME P450 2E1; DIETHYLNITROSAMINE; NITRITE; PROADIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CANCER PREVENTION; CONTROLLED STUDY; DETOXIFICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; IN VITRO STUDY; LIVER CANCER; LIVER MICROSOME METABOLISM; LONG TERM CARE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; TREATMENT DURATION;

EID: 67651247837     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.2345     Document Type: Article

References (28)

1. Blum HE. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol 2005; 11: 7391-7400
2. Rüegg C, Zaric J, Stupp R. Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality. Ann Med 2003; 35: 476-487
3. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998; 58: 409-412
4. Pentland AP, Schoggins JW, Scott GA, Khan KN, Han R. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999; 20: 1939-1944
5. Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, Kelloff GJ, Hill DL, Seibert K. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res 2000; 60: 5599-5602
6. Harris RE, Alshafie GA, Abou-Issa H, Seibert K. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res 2000; 60: 2101-2103
7. Kern MA, Schubert D, Sahi D, Schöneweiss MM, Moll I, Haugg AM, Dienes HP, Breuhahn K, Schirmacher P. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology 2002; 36: 885-894
8. Márquez-Rosado L, Trejo-Solís MC, García-Cuéllar CM, Villa-Treviño S. Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats. J Hepatol 2005; 43: 653-660
9. Verna L, Whysner J, Williams GM. N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 1996; 71: 57-81
10. Bellec G, Goasduff T, Dreano Y, Menez JF, Berthou F. Effect of the length of alkyl chain on the cytochrome P450 dependent metabolism of N-diakylnitrosamines. Cancer Lett 1996; 100: 115-123
11. Yamazaki H, Inui Y, Yun CH, Guengerich FP, Shimada T. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 1992; 13: 1789-1794
12. Janzowski C, Pool BL, Preussmann R, Eisenbrand G. Fluoro-substituted N-nitrosamines. 2. Metabolism of N-nitrosodiethylamine and of fluorinated analogs in liver microsomal fractions. Carcinogenesis 1982; 3: 155-159
13. Appel KE, Rühl CS, Hildebrandt AG. Metabolic inactivation of N-nitrosamines by cytochrome P-450 in vitro and in vivo. IARC Sci Publ 1984; 443-451
14. Wade D, Yang CS, Metral CJ, Roman JM, Hrabie JA, Riggs CW, Anjo T, Keefer LK, Mico BA. Deuterium isotope effect on denitrosation and demethylation of N-nitrosodimethylamine by rat liver microsomes. Cancer Res 1987; 47: 3373-3377
15. Mayer RT, Netter KJ, Heubel F, Hahnemann B, Buchheister A, Mayer GK, Burke MD. 7-Alkoxyquinolines: new fluorescent substrates for cytochrome P450 monooxygenases. Biochem Pharmacol 1990; 40: 1645-1655
16. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 1985; 34: 3337-3345
17. Lubet RA, Mayer RT, Cameron JW, Nims RW, Burke MD, Wolff T, Guengerich FP. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch Biochem Biophys 1985; 238: 43-48
18. Reinke LA, Moyer MJ. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos 1985; 13: 548-552
19. Sierra-Santoyo A, Hernández M, Albores A, Cebrián ME. DDT increases hepatic testosterone metabolism in rats. Arch Toxicol 2005; 79: 7-12
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
21. Zhu B, Liu GT, Wu RS, Strada SJ. Chemoprevention of bicyclol against hepatic preneoplastic lesions. Cancer Biol Ther 2006; 5: 1665-1673
22. Roomi MW, Ho RK, Sarma DS, Farber E. A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat. Cancer Res 1985; 45: 564-571
23. Ono S, Hatanaka T, Hotta H, Satoh T, Gonzalez FJ, Tsutsui M. Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 1996; 26: 681-693
24. Liu LL, Gong LK, Qi XM, Cai Y, Wang H, Wu XF, Xiao Y, Ren J. Altered expression of cytochrome P450 and possible correlation with preneoplastic changes in early stage of rat hepatocarcinogenesis. Acta Pharmacol Sin 2005; 26: 737-744
25. Buchmann A, Schwarz M, Schmitt R, Wolf CR, Oesch F, Kunz W. Development of cytochrome P-450-altered preneoplastic and neoplastic lesions during nitrosamine-induced hepatocarcinogenesis in the rat. Cancer Res 1987; 47: 2911-2918
26. Guengerich FP. Influence of nutrients and other dietary materials on cytochrome P-450 enzymes. Am J Clin Nutr 1995; 61: 651S-658S
27. Harrelson JP, Henne KR, Alonso DO, Nelson SD. A comparison of substrate dynamics in human CYP2E1 and CYP2A6. Biochem Biophys Res Commun 2007; 352: 843-849
28. Atkins WM. Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions. Annu Rev Pharmacol Toxicol 2005; 45: 291-310